Home
-
CDMO Insights: What’s Trending in the Injectable Drug Market?
GPL-1s for treating Type 2 diabetes and obesity have been a key growth driver for the bio/pharma industry as well as for CDMOs of injectables, but will the entry of oral GLP-1s and related drugs put a damper on growth prospects for injectables? What is the expected market penetration?
-
Pharma Customer–Supplier Insights: What Constitutes Value Creation?
Delivering value beyond product and price is crucial for CDMOs and suppliers to gain a competitive edge with their bio/pharma customers, but are the buy and sell side aligned in what constitutes value? The latest DCAT Benchmarking & Research study provides key insights.
-
Small-Molecule CDMO Outlook: What Lies Ahead
At the mid-point in 2026, how are small-molecule CDMOs faring? Larger CDMOs are faring well while CDMOs in early-stage capabilities face some headwinds with more challenging biotech financing
SPONSORED CONTENT
-
SPONSORED CONTENT
Trends Driving the Biopharmaceutical Industry Forward: How CDMOs Maintain Stability in a Complex Global Market
-
SPONSORED CONTENT
A new way of tackling bitterness and elevating drug palatability: ModulaSENSE® Bitter debuts at DCAT Week
-
SPONSORED CONTENT
Engineering Excellence In High Potency Manufacturing: Indena’s Integrated CDMO Platform for HPAPIs and ADCs
DCAT MEMBER COMPANY COMMUNITY
-
DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the…
-
ICYMI: Production to Prescription Podcast: A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis
The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving? In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a…
-
New DCAT Member Company Alert
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…
